Clinical Trials Logo

Filter by:
NCT ID: NCT06397235 Recruiting - Clinical trials for Hepatocellular Carcinoma Non-resectable

DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC

Start date: May 1, 2024
Phase: Phase 2
Study type: Interventional

This study is conducted to evaluate the efficacy and safety of transarterial chemoembolization with drug-eluting beads (DEB-TACE) combined with hepatic artery infusion chemotherapy (HAIC) with oxaliplatin and raltitrexed (RALOX-HAIC) versus DEB-TACE alone for unresectable large hepatocellular carcinoma (HCC).

NCT ID: NCT06397222 Recruiting - Clinical trials for Hepatocellular Carcinoma Non-resectable

Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC

Start date: May 1, 2024
Phase: Phase 2
Study type: Interventional

This study is conducted to evaluate the efficacy and safety of sintilimab, bevacizumab plus Y-90 selective internal radiation therapy (SIRT) for patients with unresectable intermediate-advanced hepatocellular carcinoma (HCC).

NCT ID: NCT06397092 Completed - Anesthesia Clinical Trials

Anesthetic Management for TA-BSM in HOCM

Start date: April 1, 2022
Phase:
Study type: Observational

To retrospectively analyze the preoperative, intraoperative and postoperative anesthesia management of patients with hypertrophic cardiomyopathy undergoing TA-BSM in the investigators' hospital, and to provide clinical basis for the development of reasonable and standardized perioperative anesthesia program for these patients.

NCT ID: NCT06397066 Recruiting - Clinical trials for Helicobacter Pylori Infection

White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Hp Infection

Start date: May 1, 2024
Phase:
Study type: Observational

By comparing the characteristics of Helicobacter pylori (Hp) infection under magnifying endoscopy and white light endoscopy, and making judgments of Hp infection status, the advantages and disadvantages of the two endoscopic examination methods are summarized to improve the accuracy of subsequent endoscopic Hp infection status judgments.

NCT ID: NCT06397053 Completed - Rectal Cancer Clinical Trials

Comparison of Robotic Versus Laparoscopic Surgery for Visceral Obesity in Mid-Low Rectal Cancer: A Propensity-Matched Analysis

Start date: December 1, 2019
Phase:
Study type: Observational

Our team has previously published articles providing detailed descriptions of the steps involved in both RS and LS. All surgeries adhered to the total mesorectal excision (TME) principle. In RS, a surgeon employed the Da Vinci Xi surgical system featuring a five-port setup, while five physicians conducted LS with a similarly configured five-port approach. Both the RS and LS doctors are experienced. The surgeries were conducted according to standard procedures, and the RS group utilized totally robotic rectal resection.

NCT ID: NCT06397014 Completed - Hernia Repair Clinical Trials

The Clinical Applications of D-type Parastomal Hernia Repair Surgery

Start date: February 1, 2018
Phase:
Study type: Observational

During the period from February 2018 to February 2022, a study was conducted on patients with parastomal hernia.There were 23 patients who underwent repair surgery for D-type colostomy hernia, while 68 patients underwent traditional laparoscopic repair surgery for hernia.The inclusion criteria were: (1) preoperative diagnosis of parastomal hernia by CT scan; (2) underwent laparoscopic repair surgery or combined laparoscopic repair with abdominal wall and stoma reconstruction surgery.The exclusion criteria were: (1) occurrence of tumor recurrence and/or new tumors during the follow-up period; (2) death or loss to follow-up during the follow-up period.

NCT ID: NCT06396975 Completed - Rectal Cancer Clinical Trials

Comparison of Short-term Outcomes of Robotic and Laparoscopic Surgery in Patients With Different Body Mass Index for Mid and Low Rectal Cancer

Start date: January 1, 2019
Phase:
Study type: Observational

Numerous comparison studies on the outcomes of robotic and laparoscopic surgery in the treatment of rectal cancer have been undertaken and reported. But there aren't many studies that compare the safety and effectiveness of the two surgery procedures used to treat people with mid and low rectal cancer who have different body mass indexes (BMIs). This study was done to organize the clinical data we had at our hospital so we could compare the perioperative effectiveness of two minimally invasive approaches for people with different BMIs.

NCT ID: NCT06396962 Completed - Clinical trials for Primary Retroperitoneal Sarcoma

Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery: a Single-center Experience

Start date: April 29, 2024
Phase:
Study type: Observational

he percentage of retroperitoneal sarcomas (RPS) among all soft tissue sarcomas ranges from 10%-15%. Surgery remains the gold standard for RPS. In this study, we analyzed the impact of surgical treatment for primary RPS on recurrence and overall mortality at a Chinese institution and identified and evaluated prognostic variables.

NCT ID: NCT06396845 Completed - Laparoscopic Clinical Trials

Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

Start date: January 1, 2019
Phase:
Study type: Observational

This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.

NCT ID: NCT06396780 Active, not recruiting - Clinical trials for Helicobacter Pylori Infection

Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication Therapy

Start date: March 30, 2024
Phase:
Study type: Observational

The aim of this study is to describe the current status of treatment adherence in children with Helicobacter pylori infection, understand the medication literacy, medication beliefs of the children, knowledge of H. pylori among caregivers, medication beliefs, medication support, and explore the influencing factors of medication adherence.